AI assistant
Biohit Oyj — Board/Management Information 2017
May 4, 2017
3304_iss_2017-05-04_6cc6eac8-b7e7-49fe-acba-382352bea774.html
Board/Management Information
Open in viewerOpens in your device viewer
Disclosure 352055
Biohit Oyj - Changes board/management/auditors
Lea Paloheimo appointed Biohit Oyj’s R&D and production director
Biohit Oyj Changes board/management/ auditors May 4, 2017 at 10:00 a.m. local time (EEST) Lea Paloheimo, PhD (clinical biochemistry), has been appointed Biohit Oyj’s R&D and production director. Lea Paloheimo has been a member of the Biohit Oyj’s management team since 2006. CEO Semi Korpela, Biohit Oyj: ‘Lea Paloheimo has over fifteen years of experience in various positions in Biohit Oyj.’ Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 [email protected] www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com